Frontotemporal Dementia (FTD): The Complete Guide for Families in BC

I did my first care navigation consultation for a family dealing with frontotemporal dementia this week. The family had been watching their father change for three years before anyone named what was happening. In that time he had lost his job, damaged relationships, spent money impulsively, and been assessed for depression and bipolar disorder. The dementia diagnosis, when it finally came, was almost a relief — because it meant his behaviour had a cause, and the cause had a name.

That gap — between the first symptoms and a correct diagnosis — averages three to four years for frontotemporal dementia. It is one of the most misdiagnosed conditions in medicine. And once diagnosed, most families find that the guidance available to them assumes Alzheimer’s disease, which is a fundamentally different condition with fundamentally different care implications.

This guide is for those families. Written specifically for BC — with local resources, Fraser Health navigation, and what families in South Surrey, White Rock, Tsawwassen, Ladner, and Langley actually have access to.

---

What frontotemporal dementia actually is

Frontotemporal dementia is not one disease. It is an umbrella term for a group of conditions that damage the frontal and temporal lobes of the brain — the regions that govern personality, behaviour, social judgment, language, and impulse control.

Researchers estimate that approximately 10% of all dementia cases are frontotemporal dementia. However, it is the most common dementia in people under the age of 60. FTD is the leading cause of early-onset dementia — dementia diagnosed before age 65 — accounting for roughly 20% of young-onset dementia cases in Canada. While Alzheimer’s is overwhelmingly a disease of later life, FTD frequently strikes people in their 40s and 50s — sometimes earlier. People with careers, young families, mortgages, and no reason to expect a dementia diagnosis.

The most common form is behavioural variant FTD (bvFTD), which primarily affects personality and behaviour. The other major forms affect language — primary progressive aphasia (PPA) — which can cause progressive loss of speech, word-finding, or language comprehension, depending on which variant is present.

---

How FTD differs from Alzheimer’s disease

This distinction matters enormously for care. Families who approach FTD with an Alzheimer’s framework will consistently misunderstand what they’re seeing.

The medication difference is especially important. The drugs commonly prescribed for Alzheimer’s — donepezil, rivastigmine, galantamine — work differently in FTD and are generally not recommended. Some evidence suggests they can worsen behavioural symptoms in bvFTD. If your family member has been diagnosed with FTD and is on a cholinesterase inhibitor, this is worth discussing explicitly with the neurologist.

---

The subtypes — why they matter for care

Behavioural variant FTD (bvFTD)

The most common form. Affects personality, impulse control, social judgment, and emotional regulation before language or memory are significantly affected. The person may:

• Lose empathy in ways that feel sudden and shocking to those who know them
• Make socially inappropriate comments or actions without apparent awareness
• Become impulsive with money, food, or behaviour (hypersexuality is reported in some cases)
• Develop rigid, repetitive behaviours or routines
• Show dramatic changes in food preferences — often toward sweet, high-carbohydrate foods
• Lose interest in hygiene and personal care without apparent distress about it
• Appear apathetic and unmotivated, or alternatively agitated and disinhibited

The hardest part for families is that the person often has no insight into these changes. They don’t believe they’ve changed. They experience their behaviour as normal. This is neurological — the brain regions that would generate self-awareness about the changes are the regions being damaged.

Primary Progressive Aphasia (PPA)

Three variants exist, each with distinct language profiles:

Semantic variant PPA: Loses understanding of word meanings. Can speak fluently but loses ability to name things or understand what words mean. “The thing you use to eat” instead of “fork.”

Non-fluent/agrammatic variant PPA: Speech becomes halting, effortful, and grammatically simplified. Understanding is often better preserved than expression.

Logopenic variant PPA: Difficulty retrieving words and repeating phrases. Often confused with Alzheimer’s because memory can also be affected.

Each variant has different implications for communication strategies, and working with a speech-language pathologist who has specific FTD experience makes a significant difference.

---

How FTD is diagnosed — and why it takes so long

The average diagnostic delay for FTD is three to four years. The reasons are understandable:

The earliest symptoms — personality change, disinhibition, poor judgment, social withdrawal — are identical to the presentation of depression, bipolar disorder, anxiety, midlife crisis, or burnout. Most people see a psychiatrist before they see a neurologist.

Memory is often preserved early, so the person and their family don’t register “dementia” as a possibility. The person may perform normally on standard cognitive tests that are designed to detect Alzheimer’s-type memory loss.

The diagnostic pathway in BC:

1. Family doctor — the starting point. Ask specifically for a referral to neurology or geriatric psychiatry with the words “possible frontotemporal dementia” or “early onset dementia.” General dementia referrals often go to services focused on Alzheimer’s.

2. Neurological assessment — includes cognitive testing using FTD-specific protocols (not just standard MMSE), detailed history from family members (essential — the person themselves often has no insight), and neuroimaging.

3. MRI — shows characteristic patterns of frontal and temporal lobe atrophy in FTD. Normal Alzheimer’s-pattern MRI with significant behavioural changes increases suspicion for FTD.

4. FDG-PET scan — shows metabolic changes in frontal and temporal lobes. More sensitive than MRI for early FTD. Not always available publicly in BC — sometimes requires private referral or clinical trial participation.

5. Lumbar puncture (CSF analysis) — can help distinguish FTD from Alzheimer’s by looking at tau and amyloid biomarkers. Being used increasingly as biomarker testing becomes more available.

6. Genetic testing — recommended if there is a family history of FTD, ALS, or Parkinson’s disease, or if the person is under 60. Three genes account for the majority of familial FTD: GRN (progranulin), MAPT (tau), and C9orf72.

In South Surrey and White Rock, the referral pathway goes through Peace Arch Hospital to Fraser Health’s neurology and geriatric psychiatry services. Wait times for non-urgent neurology referrals run four to six months. If you believe something is urgently wrong — significant behavioural changes, job loss, relationship breakdown, financial damage — frame the referral as urgent and document the functional impact explicitly in the referral letter.

If you cannot wait four to six months for specialist input, giniehealth.com connects Canadian families with geriatric specialists and neurologists within days for a written second opinion or video consultation.

---

How FTD progresses

Unlike Alzheimer’s, which follows a relatively predictable trajectory, FTD progression varies significantly by subtype and individual.

Behavioural variant FTD typically progresses in three broad phases:

Early phase (1-3 years from symptom onset): Behaviour changes are present but the person is still largely independent. May still be working, driving, managing daily life — while relationships and judgment are deteriorating. This is often when psychiatric misdiagnosis occurs.

Middle phase (2-5 years): Increasing dependency. Behavioural symptoms may intensify — agitation, wandering, compulsive behaviours. Language and motor function may begin to be affected. Daily care support becomes necessary.

Late phase: Severe cognitive and physical decline. In some people FTD overlaps with motor neuron disease (ALS) — a particularly devastating combination that requires specialist palliative planning.

Language variants (PPA) progress differently — language function deteriorates progressively while other cognitive domains may be relatively preserved for years. Eventually, as the disease spreads beyond the language networks, broader cognitive and behavioural changes emerge.

---

What care actually looks like for FTD — and where it differs from Alzheimer’s care

Behaviour management is the core challenge in bvFTD

The behaviours produced by FTD — disinhibition, apathy, compulsive behaviour, loss of empathy, impulsivity — are among the most difficult in all of dementia care. They are also the behaviours that most damage relationships, because they look intentional to those who don’t understand the disease.

The most important reframe for families: the person is not choosing these behaviours. The brain regions that would generate self-control, empathy, and social awareness are the regions being destroyed. Treating FTD behaviours as wilful is both inaccurate and exhausting.

What helps:

Structure and routine — more so than in Alzheimer’s. Predictable schedules, consistent environments, and minimised decision-making reduce behavioural episodes significantly.

Redirection over confrontation — arguing with FTD behaviour is almost never productive. The person cannot reason about their behaviour because the reasoning circuitry is damaged. Calmly redirecting to a preferred activity or environment is more effective.

Environmental modification — removing triggers. If the person is compulsively eating inappropriate foods, remove access to them rather than relying on the person to exercise restraint they neurologically cannot.

Doing things with them, not just for them

One of the most important shifts in FTD care — and one that families often discover late — is the difference between doing things for the person and doing things with them. FTD affects judgment and impulse control, but many people retain the capacity for enjoyment, connection, and participation far longer than families expect. Walking together rather than supervising a walk. Cooking alongside them with safe tasks rather than taking over the kitchen. Listening to music together rather than putting it on for them. This isn’t semantics — it preserves dignity, reduces agitation, and keeps the relationship alive in ways that purely task-oriented care cannot. The person with FTD may not be able to manage their finances or drive safely, but they can still laugh, still prefer certain foods, still enjoy a familiar face. Build care around what remains, not only around what has been lost.

Caregiver education — arguably the highest-value intervention available. Caregivers who understand FTD have dramatically better outcomes — lower burnout, fewer crisis episodes, better quality of life for the person with FTD. BRELLA Community Services, the Alzheimer Society of BC First Link program (1-800-936-6033), and the Association for Frontotemporal Degeneration (theaftd.org) all offer caregiver education resources.

Medication in FTD

There is currently no cure for frontotemporal dementia, but promising leads are emerging from ongoing research. Treatments offered for FTD are purely symptomatic, and aim in particular to alleviate behavioural problems. Certain antidepressants, anxiolytics, or serotonergic drugs can reduce agitation, producing a noticeable effect on appetite regulation and irritability.

Specifically in bvFTD:

• SSRIs (particularly sertraline and fluvoxamine) have some evidence for reducing disinhibition, compulsive behaviours, and irritability
• Trazodone has evidence for reducing behavioural symptoms including agitation and eating disturbances
• Antipsychotics are sometimes used for severe agitation but carry significant side effects in this population and should be used cautiously
• Cholinesterase inhibitors (donepezil, rivastigmine) — generally not recommended for bvFTD and may worsen symptoms

In language variants, medications play a smaller role. Speech-language pathology is the primary intervention.

Discuss all medication decisions explicitly with a neurologist or geriatric psychiatrist with FTD experience. FTD pharmacology is different enough from Alzheimer’s pharmacology that general practitioners and even general geriatricians may not be current on the specific evidence.

---

Nutrition in FTD

Dietary changes are among the most distinctive and challenging features of bvFTD.

The sweet food phenomenon: A significant proportion of people with bvFTD develop an intense preference for sweet, carbohydrate-dense foods — sweets, pastries, sugary drinks — that can appear suddenly and be dramatic. This is neurological, driven by changes in the reward and impulse control circuitry, not a lifestyle choice.

The practical implication: restricting access is more effective than relying on self-control. Remove or limit the availability of high-sugar foods in the home rather than asking the person to moderate their intake.

Hyperphagia (excessive eating): Some people with bvFTD eat compulsively, consuming food far beyond normal appetite. Monitoring food intake and limiting access to food outside mealtimes may be necessary.

Dysphagia (swallowing difficulties): Emerges in later stages as the disease affects motor control. A speech-language pathologist can assess swallowing and recommend texture modifications to prevent aspiration. This is especially important when FTD overlaps with motor neuron disease.

General nutritional principles: Support adequate protein intake for muscle preservation (particularly important as mobility declines), maintain hydration (people with FTD may not recognise thirst), and ensure regular meals to reduce food-seeking behaviour between meals.

---

Exercise and physical activity in FTD

Exercise benefits in FTD are less studied than in Alzheimer’s, but the general principles of brain health apply — and in FTD specifically, physical activity has an additional role in behaviour management.

Structured physical activity reduces behavioural symptoms. A person with bvFTD who has had regular physical exercise has fewer agitation episodes, less wandering behaviour, and better sleep. This is not coincidental — exercise engages the motor and reward systems in ways that partially compensate for the dysregulation caused by frontal lobe damage.

What works in practice:

• Walking — daily, same route, same time. Predictability reduces resistance.
• Swimming — if previously enjoyed; the rhythmic, full-body nature is often well-tolerated
• Cycling (stationary, for safety as judgment declines)
• Group exercise classes — social engagement combined with physical activity; some community centres in the South Surrey/White Rock area offer senior fitness programs

Driving and exercise: As judgment declines in FTD, safety during outdoor exercise requires supervision. Wandering risk increases. A GPS device and a consistent exercise companion are more effective than prohibiting outdoor activity.

Physiotherapy: As motor symptoms develop (particularly in variants with motor involvement), physiotherapy with a specialist in neurological conditions becomes important. Ask the family doctor for a referral — Fraser Health can provide physiotherapy through the Home Health program for eligible patients.

---

Therapies — what has evidence in FTD

Speech-language pathology — highest evidence base for language variants. Specific augmentative and alternative communication (AAC) strategies can significantly extend functional communication as verbal language deteriorates. A speech-language pathologist with experience in PPA or FTD is significantly more effective than a general speech therapist.

Occupational therapy — particularly valuable for home safety assessment, adaptive equipment, and strategies to maintain independence in daily activities as executive function declines. Fraser Health can provide OT through a case manager referral.

Music therapy — music is processed differently in the brain than language and social behaviour, and is often remarkably preserved in FTD even when other functions are significantly impaired. Can be used for mood regulation, engagement, and as a calming intervention during agitation.

Cognitive stimulation — more complex in FTD than in Alzheimer’s because executive function is impaired early. Activities need to be structured, predictable, and matched to the person’s preserved abilities rather than their deficits. Reminiscence-based activities often work well because long-term memory is frequently more preserved than in Alzheimer’s.

Caregiver support groups — specifically for FTD, not general dementia. The experience of caring for someone with bvFTD in particular is distinct from Alzheimer’s care — the behaviour patterns, the relationship dynamics, the loss of the person’s personality before physical decline — and benefits from a community of others navigating the same thing. The Association for Frontotemporal Degeneration (theaftd.org) runs online support groups accessible from BC.

---

Latest research and clinical trials (2026)

The FTD research landscape is more active than many families realise.

Gene therapy for familial FTD: The most significant research is in progranulin (GRN) mutation FTD. AviadoBio has announced progress in its clinical trial ASPIRE-FTD, testing AVB-101, a gene therapy designed to increase progranulin levels in the brain. The study is now open at 20 sites across the U.S., Canada, the U.K., and Europe. Early results show increases in progranulin levels and no serious safety concerns. Canadian sites are involved — if you or your family member has a confirmed GRN mutation, this trial may be worth exploring.

INFRONT trial: A phase 3 immune-modulating monoclonal antibody trial targeting FTD-GRN. Currently enrolling. Canadian sites exist.

What no cure means practically: Currently, treatment is symptomatic and there are no licensed disease-modifying therapies available. This is the honest current state. The gene therapy trials are promising but early-phase and limited to genetic FTD. For sporadic FTD — which represents the majority of cases — symptom management remains the primary approach.

Canadian trial access — where to go:

The most active Canadian centre for FTD research is Sunnybrook Health Sciences Centre in Toronto, which runs the ongoing Sunnybrook Dementia Study — a longitudinal research program enrolling patients with FTD, Alzheimer’s, vascular dementia, and Lewy body disease. The study includes advanced MRI analysis, genetic testing, and cognitive assessments at yearly intervals.

• Sunnybrook Health Sciences Centre (Toronto, Ontario)
• Primary Contact: Sabrina Armstrong
• Phone: (416) 480-6100 ext. 61620
• Led by Dr. Sandra Black, one of Canada’s leading dementia imaging researchers

For BC families, the pathway to trial participation typically goes through a referral to UBC Hospital or Vancouver General Hospital neurology, who can connect you with national trial networks. Ask your neurologist specifically about FTD trial eligibility.

For a complete list of active Canadian FTD trials: clinicaltrials.gov → search “frontotemporal dementia” → filter by Canada.

The Association for Frontotemporal Degeneration (theaftd.org) maintains an updated trial finder specifically for FTD — more useful than the general clinicaltrials.gov search for this condition.

---

Navigating the BC system with FTD

FTD in BC is navigated through the same Fraser Health system as other dementias, but with some important differences.

Young onset dementia services: If the person is under 65 at diagnosis, they may not fit standard senior services. Fraser Health has a Young Onset Dementia pathway — ask the case manager specifically about this. BRELLA Community Services in South Surrey, White Rock, and surrounding areas has experience with younger clients with dementia.

Disability benefits: A person with FTD who was working at diagnosis may be eligible for CPP Disability benefits, long-term disability insurance, and other income supports. This is urgent — apply early. An elder law lawyer or social worker familiar with disability claims is worth consulting.

Work and driving: Both often need to stop earlier in FTD than families expect because judgment and impulse control are affected before memory. Driving cessation in FTD is particularly important because the behavioural changes affect road safety before obvious cognitive decline. Contact RoadSafetyBC at 1-800-950-1498.

Legal documents: Power of Attorney and Representation Agreement must be established while the person still has capacity. In bvFTD this window can be shorter than families expect — seek legal advice early. Capacity can fluctuate and is domain-specific; a legal professional can assess what the person can and cannot validly consent to.

Fraser Health resources in South Surrey and White Rock:

• Older Adult Community Mental Health — White Rock: geriatric assessment and mental health support
• Fraser Health Access Line: (604) 587-3936
• Home Health referral through family doctor

Local support resources:

• BRELLA Community Services: (604) 538-0962 — brellasociety.ca
• Alzheimer Society of BC First Link: 1-800-936-6033
• Association for Frontotemporal Degeneration: theaftd.org (best FTD-specific resource available)
• Rare Dementia Support Canada: raredementiasupport.ca — specifically covers FTD

---

What families need to know that nobody tells them

FTD is harder on families than almost any other dementia. The reason is timing and nature. In Alzheimer’s, the person’s personality is usually preserved for years while memory declines — families lose the person slowly, with the relationship largely intact. In bvFTD, the personality changes first. The person the family knew disappears — their warmth, their empathy, their judgment — while they are physically healthy and look completely normal. This is a particular kind of grief that gets very little recognition.

The behaviour is not personal. The person with FTD is not choosing cruelty, indifference, or impulsivity. The brain regions that would generate empathy, self-awareness, and social control are being destroyed. Understanding this doesn’t make it less painful, but it changes the relationship to the behaviour.

Caregiver burnout in FTD is extremely high. Higher than in Alzheimer’s. The combination of young onset (often the spouse is still working, children may be at home), dramatic personality change, and the loss of the partnership that typically carries a family through hard times creates enormous strain. Respite care, support groups, and professional counselling are not optional extras — they are clinical necessities.

Genetic counselling matters. If there is a family history of FTD, ALS, or Parkinson’s, or if the person is under 60 at diagnosis, genetic testing and counselling is worth pursuing. The implications for adult children are significant and require proper specialist guidance.

---

Getting help in South Surrey, White Rock, and surrounding areas

If your family has just received an FTD diagnosis, or if you’ve been watching someone change for months or years without a name for it, a structured conversation about what you’re actually dealing with and what your options are can save months of confusion.

My free care navigation call is designed for exactly this — not a sales call for home care services, but a focused conversation about your specific situation, what the BC system offers for FTD specifically, and what your realistic options are over the next 6-12 months.

If you need specialist input faster than the BC referral system allows, giniehealth.com connects Canadian families with geriatric neurologists and specialists — written opinions available within days.

Free resource: Get the BC Dementia Caregiver Kit — 9 printable templates including daily care logs, behaviour trackers, doctor visit prep sheets, and conversation scripts. Many of these apply directly to FTD care.

---

This article is part of the Aging at Home series. Also see: The Complete Guide to Caring for a Parent with Dementia at Home · South Surrey Dementia Guide · White Rock Dementia Guide

Gurjot Narwal · Founder, Gini Advanced Care Hospital · Owner, Home Instead White Rock · Building Mapa Care · Fifteen years building healthcare systems that measure whether patients actually get better.